Generic/Discount HIV Drug Access in the Developing World
- Gilead Sciences Signs Deals With Three Indian Pharmaceutical Companies to Promote Low-Cost HIV Drugs in Developing Countries (August 3, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Attempts to Limit Intellectual Property Rights in India Could Harm Access to Generic Drugs (July 26, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Generic Drugs Make Dent in Global AIDS Pandemic (July 16, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Donor Governments Need to Conduct More Post-Market Oversight of Generic Medicines (July 13, 2012)
In Kaiser Daily Health Policy Report, from Henry J. Kaiser Family Foundation
- Trade Agreements Could Harm Access to Antiretroviral Drugs in Asia, Pacific, Experts and Activists Warn (July 13, 2012)
In Kaiser Daily Health Policy Report, from Henry J. Kaiser Family Foundation
- Research Roundup: Use of Generic Drugs Reduces Costs of AIDS Relief (July 13, 2012)
In Kaiser Daily Health Policy Report, from Henry J. Kaiser Family Foundation
- Growing Number of Countries Adopting Flexible Intellectual Property Regulations After India Issues Country's First Compulsory License (June 22, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Joint UNAIDS/UNDP Briefing Highlights Potential Impacts of Free Trade Agreements on Public Health (June 4, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 Trade Officials at WIPO Fail to Make Progress on Proposals to Improve Access to Generic Medicines (May 30, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Kenyan Court Ruling Upholds Access to Generic Drugs (April 23, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- No One Funding Model Is Sufficient to Ensure Availability of Life-Saving Drugs (April 6, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Sanofi Teams Up With India to Make Cheap Antiretrovirals in South Africa (April 2, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 First-Ever Compulsory License Issuance in India Could Have Implications for HIV Medication (March 14, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Novartis Defends Challenge to Indian Medicines Patent Law (February 28, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Activists Protest Novartis Challenge to Indian Patent Law (February 28, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Janssen Block Patent Pool Access to Darunavir, Rilpivirine and Etravrine (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approval of Generic ARVs (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- India: Free-Trade Proposal May Affect Supply of AIDS Drugs (February 13, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- South Africa Announces AIDS Drug Venture With Swiss Lonza (February 13, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Proposed Intellectual Property Agreement Between E.U., India Could Affect Generic Drug Exports, Advocacy Groups Say (February 10, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 J&J Will Not Join Medicines Patent Pool; Company's Pharma Head Says Mechanism Could "Cause Disaster" (January 3, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
|
Advertisement
|
Email
Glossary
